Why Gritstone Bio (GRTS) Stock Is Down 64% Today
Why Gritstone Bio (GRTS) Stock Is Down 64% Today
Gritstone bio Inc. (NASDAQ:GRTS) shares are trading lower by 64.2% to $0.07 during Thursday's session after the company announced it voluntarily filed for Chapter 11 restructuring.
Gritstone bio Inc.（纳斯达克股票代码：GRTS）宣布自愿申请第11章重组后，该公司股价在周四的交易中下跌了64.2％，至0.07美元。
What Else: Gritstone Bio says the company plans to use the court-supervised restructuring to preserve value while exploring strategic alternatives. Gritstone is in talks with a potential bidder or plan sponsor and hopes to present a deal to the court soon.
还有什么：Gritstone Bio表示，该公司计划利用法院监督的重组来保持价值，同时探索战略替代方案。Gritstone正在与潜在的竞标者或计划发起人进行谈判，并希望尽快向法院提交协议。
The company also says it remains focused on developing next-generation vaccines and immunotherapies, including its promising GRANITE cancer treatment, while continuing normal operations during the bankruptcy process. Gritstone added that the company aims to minimize the impact on employees, vendors and stakeholders through "first day" motions.
该公司还表示，它仍然专注于开发下一代疫苗和免疫疗法，包括其有前途的GRANITE癌症治疗方法，同时在破产过程中继续正常运营。Gritstone补充说，该公司的目标是通过 “第一天” 动议将对员工、供应商和利益相关者的影响降至最低。
Read Also: Delta's Turbulent Q3: Mixed Results And Tech Troubles Cloud Holiday Outlook
另请阅读：达美航空动荡的第三季度：业绩喜忧参半和技术问题让假日前景黯淡
According to data from Benzinga Pro, GRTS has a 52-week high of $3.33 and a 52-week low of $0.07.
根据Benzinga Pro的数据，GRTS的52周高点为3.33美元，52周低点为0.07美元。
